7001 to 7010 of 96601 results

Almirall gains rights for IBS drug linaclotide in Mexico


Spain's largest drugmaker Almirall (ALM. MC) says it has reached an agreement with USA-based Forest Laboratories…

AlmirallForest LaboratoriesGastro-intestinalsLicensinglinaclotidePharmaceuticalSouth America

Edison analysts' take on Basilea outlook


The protracted development of antibiotic ceftobiprole has left Swiss biotech firm Basilea Pharmaceutica…

Antibiotics and Infectious diseasesBasilea PharmaceuticaBiotechnologyceftobiproleFinancialisavuconazoleOncologyResearchToctino

Sunovion files two sNDAs for Latuda with FDA


Sunovion Pharmaceuticals, a US subsidiary of Japanese drug major Dainippon Sumitomo (TYO: 4506) has submitted…

Dainippon Sumitomo PharmaLatudaNeurologicalNorth AmericaPharmaceuticalRegulationSunovion

EAHP discusses Clinical Trial regulation with Commission, voicing some concerns


The European Association of Hospital Pharmacists (EAHP) last week met with officials at the European…


Australia leading world in medicines Code, claims trade group


Australia is a world leader in pharmaceutical industry conduct, and will continue to work towards further…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

Direct-to-consumer drug ads will be banned in Moldova


The government of Moldova has published a draft law that would make direct-to-consumer (DTC) advertising…

EuropeMarkets & MarketingPharmaceutical

Jazz Pharma sells women's health business to Meda for $95 million


US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

Lundbeck takes 5% stake in Biotie; amends Selincro licensing deal


Danish CNS drug specialist Lundbeck A/S (LUND: DC) said this morning that it has made an investment of…

BiotechnologyBiotie TherapiesFinancialLicensingLundbeckMergers & AcquisitionsNeurologicalPharmaceuticalSelincro

7001 to 7010 of 96601 results

Back to top